- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 17.01. | ICR researchers uncover genes responsible for tumour progression in prostate cancer | ||
| 17.01. | PM Society Awards 2025 - tickets now on sale | ||
| 16.01. | Eli Lilly's Omvoh granted FDA approval to treat Crohn's disease in adults | ||
| 16.01. | Novo Nordisk and Valo Health expand alliance for cardiometabolic diseases | ||
| 16.01. | Santhera's Duchenne muscular dystrophy drug Agamree accepted by SMC | ||
| 15.01. | AbbVie and Simcere to advance multiple myeloma candidate in partnership worth over $1bn | ||
| 15.01. | Biogen/Eisai announce FDA BLA acceptance for injectable Alzheimer's drug | ||
| 15.01. | Regeneron shares positive phase 3 results for Libtayo in high-risk skin cancer | ||
| 14.01. | J&J expands neuroscience capabilities with $14.6bn Intra-Cellular acquisition | ||
| 14.01. | Eli Lilly to acquire Scorpion's solid tumour programme in deal worth $2.5bn | ||
| 14.01. | Boehringer gains access to Synaffix's ADC technology through $1.3bn licensing deal | ||
| 13.01. | Gilead and LEO enter inflammatory disease partnership worth up to $1.7bn | ||
| 13.01. | GSK to expand gastrointestinal cancer pipeline with $1bn IDRx acquisition | ||
| 13.01. | Sanofi announces positive phase 3 results for subcutaneous Sarclisa in multiple myeloma | ||
| 10.01. | Bayer's non-hormonal menopause drug shows promise in phase 3 breast cancer trial | ||
| 10.01. | Pfizer shares positive late-stage results for sasanlimab combination in bladder cancer | ||
| 10.01. | Eli Lilly and Alchemab Therapeutics partner to develop new ALS therapies | ||
| 09.01. | AstraZeneca/Merck's Lynparza recommended by NICE to treat advanced breast cancer | ||
| 09.01. | Sanofi and Alloy Therapeutics enter central nervous system deal worth over $427m | ||
| 09.01. | FDA accepts updated protocol for Annovis' phase 3 Alzheimer's disease study | ||
| 08.01. | Bristol Myers Squibb shares positive phase 3 results for Sotyktu in psoriatic arthritis | ||
| 08.01. | MHRA approves Italfarmaco's Duvyzat to treat Duchenne muscular dystrophy | ||
| 08.01. | Axsome announces positive results from phase 3 Alzheimer's disease programme | ||
| 07.01. | Sanofi and SK bioscience expand pneumococcal vaccine collaboration | ||
| 07.01. | Prostate cancer blood test with 'unprecedented accuracy' cuts biopsies by 50% |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
